Can an arthritis drug stop lung cancer in former smokers?
Knowledge-focused
Ongoing
This study tests whether canakinumab, a drug that blocks inflammation, can lower certain proteins linked to cancer growth in former smokers at high risk. About 41 participants will provide cheek, nose, and blood samples before and after treatment. The goal is to see if the drug c…
Phase: PHASE2 • Sponsor: Peter Shields • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC